DMPK and myotonic dystrophy type 1: Sequencing of the non-coding part of DMPK in the patient’s sample confirmed an increased number of CTG repeats and therefore the diagnosis of DM1, suggesting that RNA sequencing could be helpful in determining the molecular diagnosis of sudden death in cases where the exome sequencing data are inconclusive.